• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Multidrug-resistant bacteria from chickens pose risk to human health

Bioengineer by Bioengineer
November 4, 2016
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Washington, DC – November 4, 2016 – Isolates of a common poultry pathogen collected from animals in Indian bird markets were mostly resistant to multiple classes of antibiotics. The study provides the first data on prevalence and isolation of Helicobacter pullorum in India. The research is published November 4 in Applied and Environmental Microbiology, a journal of the American Society for Microbiology.

In the study, the investigators sequenced the genomes of 11 isolates of the pathogen, H. pullorum, from broiler and free range chickens from markets in Hyderabad, India. Each contained five or six well characterized antimicrobial resistance genes. The isolates were resistant to fluoroquinolones, cephalosporins, sulfonamides, and macrolide antibiotics, as well as others. Additionally, they produced extended spectrum β-lactamases, enzymes that rendered them resistant to penicillin family antibiotics.

Virulence screening identified 182 important virulence genes in the isolates.

Coauthor Niyaz Ahmed, PhD, Professor of Biotechnology & Bioinformatics, University of Hyderabad, India, said that H. pullorum could potentially be pathogenic in poultry and in humans, and explained that cases have been reported of human enteric disease caused by this bacterium. He also said that it carries a toxin that can interfere with the cell cycle, and cause DNA damage that can lead to cancer.

H. pullorum could become a public health concern, said Ahmed, because of the cancer-causing potential, and because "in countries like India, H. pullorum from poultry could be multi-resistant already because of the prevailing animal husbandry practices."

The lack of research on the prevalence of H. pullorum in India provided the impetus for the study, said Ahmed. "We targeted wet market poultry outlets for our sampling, keeping in mind that poultry in India are often fed with antibiotics to promote weight gain. These practices most likely boost spread of drug-resistant pathogens among animals and humans, posing a significant public health risk."

"Our study suggests that chickens could be a major source for transmission of emerging MDR pathogen, H. pullorum, from poultry to humans," the investigators concluded. Additionally, they wrote, the study strongly supports the hypothesis that this species is an emerging pathogen, as it is closely related to established pathogens such as Campylobacter jejuni. Given the prevalence of H. pullorum in Indian chicken, as described in the study, the half billion Indians who eat chicken, and the fact that chicken consumption is growing at a huge 12 percent per year, the potential for spreading multi-drug resistance is "alarming," the researchers wrote.

###

The American Society for Microbiology is the largest single life science society, composed of over 48,000 scientists and health professionals. ASM's mission is to promote and advance the microbial sciences.

ASM advances the microbial sciences through conferences, publications, certifications and educational opportunities. It enhances laboratory capacity around the globe through training and resources. It provides a network for scientists in academia, industry and clinical settings. Additionally, ASM promotes a deeper understanding of the microbial sciences to diverse audiences.

Media Contact

Aleea Khan
[email protected]
202-942-9365
@ASMnewsroom

http://www.asm.org

Share12Tweet8Share2ShareShareShare2

Related Posts

Oxygen-Enhanced Dual-Section Microneedle Patch Improves Drug Delivery and Boosts Photodynamic and Anti-Inflammatory Treatment for Psoriasis

February 7, 2026

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

February 7, 2026

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

February 7, 2026

Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Oxygen-Enhanced Dual-Section Microneedle Patch Improves Drug Delivery and Boosts Photodynamic and Anti-Inflammatory Treatment for Psoriasis

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.